Letter

NICE and its value judgments: Option of safe “understudy” treatments should be available

BMJ 2004; 329 doi: 10.1136/bmj.329.7468.740 (Published 23 September 2004)
Cite this as: BMJ 2004;329:740.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Woody Caan, professor of public health (a.w.caan@apu.ac.uk)
  1. APU, Chelmsford, Essex CM1 1SQ

    EDITOR—The National Institute for Clinical Excellence (NICE) aims for the highest attainable standards of care.1 The bedrock of its advice is published evidence of benefits from treatment (mainly pharmaceuticals).


    Embedded Image

    In the report accepted in May consideration of safety issues focused on invasive surgical and diagnostic procedures, and the “judgment” on risk assumed that such risks are small and …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular